Physician profile
Michael N Brown
NPI 1104866102
$2,395.67
in general payments reported to CMS, 2019-2025
14 companies · $28.56 in 2025
The $28.56 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,825 · 2020: $214 · 2021: $166 · 2023: $162 · 2025: $28.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $1,101.00 | 2019 | |
| Stryker Corporation | $803.37 | 2019-2021 | |
| Abbott Laboratories | $141.73 | 2023 | Proclaim |
| Paragon 28, INC. | $87.97 | 2019 | |
| Zimmer Biomet Holdings, INC. | $38.95 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $36.56 | 2019-2020 | |
| Organogenesis INC. | $33.70 | 2019 | |
| Bioventus LLC | $28.80 | 2021 | |
| Curonix LLC | $28.56 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kci USA, INC. | $25.68 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.31 | 2023 | Exparel |
| Osiris Therapeutics INC. | $19.34 | 2019 | |
| Merck Sharp & Dohme LLC | $17.65 | 2019 | |
| Smith+Nephew, INC. | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.